Yigal Nochomovitz Analyst PerformanceDirector, Biotech Equity Research at CitigroupYigal Nochomovitz is a stock analyst at Citigroup focused in the healthcare sector, covering 51 publicly traded companies. Over the past year, Yigal Nochomovitz has issued 120 stock ratings, including buy, hold, and sell recommendations. While full access to Yigal Nochomovitz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yigal Nochomovitz's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings189 Last 11 YearsBuy Recommendations82.97% 151 Buy RatingsCompanies Covered51 Unique Companies Ratings Distribution182RatingsDistribution of strong buy, buy, hold, and sell ratings by Yigal Nochomovitz.RatingPercentageCount Strong Buy0.0%0 ratings Buy83.0%151 ratings Hold13.2%24 ratings Sell3.8%7 ratingsOut of 182 total stock ratings issued by Yigal Nochomovitz at Citigroup, the majority (83.0%) have been Buy recommendations, followed by 13.2% Hold and 3.8% Sell.Best & Worst CallsBest Call0000.0%ZLABDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%UBXJun 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.1% of companies on NASDAQ49 companiesNYSE2.0% of companies on NYSE1 companyOTCMKTS2.0% of companies on OTCMKTS1 companyYigal Nochomovitz, an analyst at Citigroup, currently covers 51 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare50 companies98.0%Miscellaneous1 company2.0%Yigal Nochomovitz of Citigroup specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY38 companies74.5%PHARMACEUTICALS11 companies21.6%Miscellaneous1 company2.0%HEALTHCARE EQUIPMENT & SUPPLIES1 company2.0% Yigal Nochomovitz's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsNBIXNeurocrine Biosciences9/3/2026Boost Price Target$158.42$253.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical9/3/2026Lower Price Target$14.89$28.00Buy$0.0000.00% ROIATTOAttovia Therapeutics8/31/2026Initiated Coverage$20.70$30.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals8/27/2026Reiterated Rating$98.51Market Outperform$0.0000.00% ROIZYMEZymeworks8/26/2026Boost Price Target$29.11$38.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics8/25/2026Reiterated Rating$57.08Market Outperform$0.0000.00% ROIACADACADIA Pharmaceuticals8/25/2026Boost Price Target$30.39$40.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical8/20/2026Boost Price Target$25.33$58.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals8/18/2026Lower Price Target$5.34$17.00Buy$0.0000.00% ROIAVBPArriVent BioPharma8/13/2026Lower Price Target$31.46$40.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LENZLENZ Therapeutics8/12/2026Reiterated Rating$5.21Buy$0.0000.00% ROIOLMAOlema Pharmaceuticals8/11/2026Lower Price Target$10.25$59.00Buy$0.0000.00% ROIARVNArvinas8/10/2026Lower Price Target$8.75$21.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals8/10/2026Boost Price Target$29.21$39.00Buy$0.0000.00% ROIARDXArdelyx8/10/2026Lower Price Target$4.01$11.00Buy$0.0000.00% ROIZLABZai Lab8/7/2026Boost Price Target$20.88$45.00Buy$0.0000.00% ROIRIGLRigel Pharmaceuticals8/6/2026Reiterated Rating$40.48Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals8/6/2026Reiterated Rating$105.79Outperform$0.0000.00% ROITVTXTravere Therapeutics8/5/2026Boost Price Target$56.02$85.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals8/5/2026Reiterated Rating$27.15Market Outperform$0.0000.00% ROIKRYSKrystal Biotech8/4/2026Boost Price Target$312.57$386.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics8/4/2026Boost Price Target$49.57$88.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences7/31/2026Boost Price Target$166.80$249.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics7/22/2026Reiterated Rating$48.15Market Outperform$0.0000.00% ROILGNDLigand Pharmaceuticals7/21/2026Initiated Coverage$298.26$387.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals6/29/2026Boost Price Target$25.32$35.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals6/15/2026Reiterated Rating$99.35Outperform$0.0000.00% ROITVTXTravere Therapeutics6/15/2026Boost Price Target$53.54$70.00Buy$0.0000.00% ROISTTKShattuck Labs6/5/2026Upgrade$4.80$7.00Buy$0.0000.00% ROITVTXTravere Therapeutics6/3/2026Boost Price Target$45.08$62.00Buy$0.0000.00% ROIZBIOZenas BioPharma6/3/2026Reiterated Rating$17.13Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals6/2/2026Initiated Coverage$96.33$145.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics5/27/2026Reiterated Rating$51.59Market Outperform$0.0000.00% ROISPTXSeaport Therapeutics5/26/2026Initiated Coverage$17.50$35.00Buy$0.0000.00% ROIKRROKorro Bio5/18/2026Initiated Coverage$10.18$21.00Buy$0.0000.00% ROIKRROKorro Bio5/18/2026Initiated Coverage$9.15$21.00Buy$0.0000.00% ROIZBIOZenas BioPharma5/14/2026Reiterated Rating$19.93Buy$0.0000.00% ROIRIGLRigel Pharmaceuticals5/13/2026Reiterated Rating$29.37$81.00Buy$0.0000.00% ROIAVBPArriVent BioPharma5/13/2026Lower Price Target$28.91$43.00Buy$0.0000.00% ROILENZLENZ Therapeutics5/13/2026Lower Price Target$7.93$20.00Buy$0.0000.00% ROISmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.Click here to learn this company's name for free todayLXRXLexicon Pharmaceuticals5/11/2026Boost Price Target$2.36$3.10Buy$0.0000.00% ROIZLABZai Lab5/8/2026Lower Price Target$18.63$44.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals5/8/2026Lower Price Target$22.40$32.00Buy$0.0000.00% ROIRIGLRigel Pharmaceuticals5/7/2026Lower Price Target$26.24$69.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics5/6/2026Boost Price Target$52.38$82.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences5/6/2026Boost Price Target$144.93$246.00Buy$0.0000.00% ROITVTXTravere Therapeutics5/5/2026Boost Price Target$44.91$59.00Buy$0.0000.00% ROIKRYSKrystal Biotech5/5/2026Boost Price Target$284.93$378.00Buy$0.0000.00% ROIBMEABiomea Fusion5/5/2026Initiated Coverage$1.48Outperform$0.0000.00% ROIORICOric Pharmaceuticals5/5/2026Lower Price Target$9.26$16.00Buy$0.0000.00% ROIARVNArvinas5/4/2026Boost Price Target$10.51$24.00Buy$0.0000.00% ROIAVBPArriVent BioPharma4/24/2026Boost Price Target$31.14$45.00Buy$0.0000.00% ROILGNDLigand Pharmaceuticals4/15/2026Boost Price Target$225.09$282.00Buy$0.0000.00% ROITVTXTravere Therapeutics4/14/2026Boost Price Target$30.70$53.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences4/7/2026Boost Price Target$131.09$242.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals4/1/2026Reiterated Rating$40.40$41.00Neutral$0.0000.00% ROIAPLSApellis Pharmaceuticals3/31/2026Downgrade$40.39Hold$0.0000.00% ROIBMEABiomea Fusion3/27/2026Boost Price Target$1.33$7.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/26/2026Boost Price Target$21.84$13.00Sell$0.0000.00% ROILENZLENZ Therapeutics3/26/2026Lower Price Target$8.66$26.00Buy$0.0000.00% ROILGNDLigand Pharmaceuticals3/24/2026Boost Price Target$198.87$276.00Buy$0.0000.00% ROIARVNArvinas3/19/2026Boost Price Target$10.79$21.00Buy$0.0000.00% ROIZBIOZenas BioPharma3/17/2026Lower Price Target$23.46$41.00Buy$0.0000.00% ROIOLMAOlema Pharmaceuticals3/17/2026Boost Price Target$15.22$62.00Buy$0.0000.00% ROICADLCandel Therapeutics3/13/2026Lower Price Target$4.67$22.00Buy$0.0000.00% ROISTTKShattuck Labs3/13/2026Boost Price Target$5.99$7.00Neutral$0.0000.00% ROIDRTSAlpha Tau Medical3/11/2026Boost Price Target$6.80$9.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/10/2026Boost Price Target$17.95$9.00Sell$0.0000.00% ROILXRXLexicon Pharmaceuticals3/10/2026Boost Price Target$1.69$2.30Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/9/2026Boost Price Target$15.56$35.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/6/2026Boost Price Target$23.90$33.00Buy$0.0000.00% ROIARVNArvinas3/5/2026Boost Price Target$13.62$18.00Buy$0.0000.00% ROIRCUSArcus Biosciences3/5/2026Boost Price Target$21.88$45.00Buy$0.0000.00% ROIARCTArcturus Therapeutics3/4/2026Boost Price Target$7.58$8.00Neutral$0.0000.00% ROISGPSpyglass Pharma3/3/2026Initiated Coverage$26.73$42.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals3/2/2026Boost Price Target$22.00$57.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals2/25/2026Lower Price Target$21.18$44.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/24/2026Boost Price Target$11.71$17.00Buy$0.0000.00% ROISMMTSummit Therapeutics2/24/2026Reiterated Rating$16.09Buy$0.0000.00% ROIIDYAIDEAYA Biosciences2/19/2026Boost Price Target$30.92$65.00Buy$0.0000.00% ROIKRYSKrystal Biotech2/18/2026Boost Price Target$287.84$371.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics2/16/2026Reiterated Rating$53.07Buy$0.0000.00% ROINBIXNeurocrine Biosciences2/12/2026Boost Price Target$123.30$204.00Buy$0.0000.00% ROISMMTSummit Therapeutics1/30/2026Reiterated Rating$15.40Market Outperform$0.0000.00% ROICRSPCRISPR Therapeutics1/30/2026Reiterated Rating$53.35Market Outperform$0.0000.00% ROIKRYSKrystal Biotech1/12/2026Boost Price Target$272.12$336.00Buy$0.0000.00% ROIARDXArdelyx1/9/2026Boost Price Target$7.00$14.00Buy$0.0000.00% ROISTTKShattuck Labs1/6/2026Boost Price Target$3.89$4.00Neutral$0.0000.00% ROIACADACADIA Pharmaceuticals1/6/2026Boost Price Target$26.15$36.00Buy$0.0000.00% ROIKRYSKrystal Biotech1/6/2026Upgrade$244.71$309.00Buy$0.0000.00% ROIALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.See the 5 stocks to avoidARVNArvinas1/6/2026Upgrade$11.17$15.00Buy$0.0000.00% ROIARCTArcturus Therapeutics1/6/2026Lower Price Target$6.52$7.00Neutral$0.0000.00% ROISLDBSolid Biosciences12/17/2025Reiterated Rating$5.82Market Outperform$0.0000.00% ROIRCUSArcus Biosciences12/12/2025Reiterated Rating$21.58Buy$0.0000.00% ROIOLMAOlema Pharmaceuticals12/12/2025Boost Price Target$31.58$60.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical12/10/2025Lower Price Target$4.80$7.00Buy$0.0000.00% ROILGNDLigand Pharmaceuticals12/9/2025Initiated Coverage$184.67$270.00Buy$0.0000.00% ROIZYMEZymeworks12/3/2025Initiated Coverage$25.10Outperform$0.0000.00% ROIORICOric Pharmaceuticals11/17/2025Boost Price Target$11.99$16.00Buy$0.0000.00% ROICADLCandel Therapeutics11/14/2025Lower Price Target$4.65$24.00Buy$0.0000.00% ROIARCTArcturus Therapeutics11/13/2025Lower Price Target$7.91$9.00Neutral$0.0000.00% ROICRSPCRISPR Therapeutics11/11/2025Reiterated Rating$54.58$77.00Buy$0.0000.00% ROIAVBPArriVent BioPharma11/11/2025Lower Price Target$19.21$31.00Buy$0.0000.00% ROIBMEABiomea Fusion11/10/2025Lower Price Target$1.37$6.00Buy$0.0000.00% ROIONCBeOne Medicines11/10/2025Boost Price Target$329.20$405.00Buy$0.0000.00% ROISLDBSolid Biosciences11/5/2025Lower Price Target$3.93$14.00Buy$0.0000.00% ROIKRYSKrystal Biotech11/4/2025Boost Price Target$197.85$198.00Neutral$0.0000.00% ROICRBUCaribou Biosciences11/3/2025Boost Price Target$2.93$8.00Buy$0.0000.00% ROIARDXArdelyx11/3/2025Boost Price Target$5.88$11.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals10/31/2025Lower Price Target$21.47$45.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences10/29/2025Boost Price Target$135.35$203.00Buy$0.0000.00% ROIRCUSArcus Biosciences10/29/2025Boost Price Target$20.23$56.00Buy$0.0000.00% ROIZBIOZenas BioPharma10/28/2025Boost Price Target$30.00$46.00Buy$0.0000.00% ROIARCTArcturus Therapeutics10/23/2025Downgrade$11.54$12.00Neutral$0.0000.00% ROINBIXNeurocrine Biosciences10/21/2025Initiated Coverage$141.33$175.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals10/21/2025Initiated Coverage$20.94$33.00Buy$0.0000.00% ROISMMTSummit Therapeutics10/20/2025Boost Price Target$20.99$40.00Buy$0.0000.00% ROIRCUSArcus Biosciences10/13/2025Boost Price Target$14.70$54.00Buy$0.0000.00% ROIARCTArcturus Therapeutics10/10/2025Reiterated Rating$19.68Buy$0.0000.00% ROIMRUSMerus9/29/2025Downgrade$68.89$97.00Neutral$0.0000.00% ROIAVBPArriVent BioPharma8/12/2025Reiterated Rating$17.42$33.00Buy$00.0000.00% ROIARCTArcturus Therapeutics8/12/2025Reiterated Rating$11.39$49.00Buy$0.0000.00% ROIOLMAOlema Pharmaceuticals8/12/2025Boost Price Target$4.57$21.00Buy$00.0000.00% ROIZLABZai Lab8/11/2025Reiterated Rating$34.96$69.00Buy$00.0000.00% ROIBMEABiomea Fusion8/11/2025Lower Price Target$1.55$7.00Buy$0.0000.00% ROIZYMEZymeworks8/11/2025Boost Price Target$11.94$22.00Buy$00.0000.00% ROILXRXLexicon Pharmaceuticals8/7/2025Boost Price Target$1.12$1.90Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals8/5/2025Boost Price Target$12.59$51.00Buy$00.0000.00% ROIKRYSKrystal Biotech8/5/2025Reiterated Rating$135.38$166.00Neutral$000.0000.00% ROILENZLENZ Therapeutics7/31/2025Reiterated Rating$30.58$49.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals7/29/2025Boost Price Target$18.50$46.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/22/2025Initiated Coverage$13.32Sell$00.0000.00% ROIBMEABiomea Fusion7/16/2025Lower Price Target$1.87$9.00Buy$0.0000.00% ROIPROKProKidney7/9/2025Reiterated Rating$4.70$9.00Buy$0.0000.00% ROISLDBSolid Biosciences6/26/2025Initiated Coverage$4.74$14.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals5/22/2025Lower Price Target$17.49$41.00Buy$0.0000.00% ROIKRYSKrystal Biotech5/16/2025Lower Price Target$130.60$155.00Neutral$000.0000.00% ROIARVNArvinas5/5/2025Lower Price Target$7.63$9.50Neutral$00.0000.00% ROIARDXArdelyx5/2/2025Lower Price Target$4.13$10.00Buy$0.0000.00% ROISMMTSummit Therapeutics3/26/2025Set Price Target$15.86$35.00$00.0000.00% ROIThe $15 Gold Fund That Pays Up to $1,152/Month (Ad)Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.Discover the gold income fund before the next payout dateLENZLENZ Therapeutics3/20/2025Boost Price Target$26.29$47.00Buy$00.0000.00% ROIZYMEZymeworks3/7/2025Boost Price Target$12.00$19.00Buy$00.0000.00% ROIARVNArvinas3/7/2025Lower Price Target$18.28$19.00Neutral$00.0000.00% ROIRIGLRigel Pharmaceuticals3/6/2025Boost Price Target$20.18$55.00Buy$00.0000.00% ROISNDXSyndax Pharmaceuticals3/4/2025Lower Price Target$14.48$42.00Buy$00.0000.00% ROICADLCandel Therapeutics2/20/2025Initiated Coverage$10.47$25.00Buy$0.0000.00% ROIKRYSKrystal Biotech2/20/2025Boost Price Target$181.64$215.00Neutral$000.0000.00% ROICRSPCRISPR Therapeutics2/18/2025Lower Price Target$52.29$82.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.